Metraipolis › archive › dc_125e4030b026

Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients — Europe PMC PMID:36355808

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36355808
DOI
10.1371/journal.pone.0276751
License (as archived)
solo-consultazione
Archived
2026-10-08T03:01:40.148Z
SHA-256 of the archived text
cb86e6ce8b1fb878899eb09322acfe1588e166e7a0e8e8e013ec4d4e01be3736
Stable URL of this page
https://metraipolis.com/documento/dc_125e4030b026

How to cite

Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients — Europe PMC PMID:36355808 — Europe PMC (en), https://europepmc.org/article/MED/36355808 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_125e4030b026 (Metraipolis archive dc_125e4030b026, sha256 cb86e6ce8b1fb878899eb09322acfe1588e166e7a0e8e8e013ec4d4e01be3736)
BibTeX
@misc{dc125e4030b026,
  title = {Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients — Europe PMC PMID:36355808},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36355808},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_125e4030b026; sha256 cb86e6ce8b1fb878899eb09322acfe1588e166e7a0e8e8e013ec4d4e01be3736},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36355808. Agents can read the archived copy with the MCP tool read_document.